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Abstract
There is a need for brief HIV prevention interventions that can be disseminated and implemented
widely. This article reports the results of a small randomized field experiment that compared the
relative effects of a brief 2-session counselor-delivered computer-tailored intervention and a
control condition. The intervention is designed for use with African American, non-Hispanic
white and Hispanic males and females who may be at risk of HIV through unprotected sex, selling
sex, male to male sex, injecting drug use or use of stimulants. Participants (n=120) were recruited
using a quota sampling approach and randomized using block randomization, which resulted in 10
male and 10 female participants of each racial/ethnic group (i.e. African-American, non-Hispanic
white and Hispanic) being assigned to either the intervention or a control arm. In logistic
regression analyses using a generalized estimating equations approach, at 3-month followup,
participants in the intervention arm were more likely than participants in the control arm to report
condom use at last sex (Odds ratio [OR] = 4.75; 95% Confidence interval [C.I.] = 1.70, 13.26; p =
0.003). The findings suggest that a brief tailored intervention may increase condom use. Larger
studies with longer followups are needed to determine if these results can be replicated.
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Introduction
As of October, 2012, the CDC Compendium of Evidence-Based HIV Behavioral
Interventions risk reduction chapter included 74 interventions that have demonstrated
efficacy in reducing HIV risk behaviors [1]. Many of these are designed for specific risk
groups (e.g. men who have sex with men [MSM], people who inject drugs [PWID],
commercial sex workers, etc.) and demographic groups (e.g. African-American women,
African-American men, Hispanic men, Hispanic women, etc.). These interventions have
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demonstrated efficacy in reducing sexual behaviors and injecting practices that place people
in these groups at risk of HIV infection or transmission [2–6]. Despite evidence of their
efficacy and efforts to promote their use, widespread diffusion and adoption of evidence-
based interventions has been slow [7]. One reason is that many of these interventions are
complex, multi-session and resource intensive, which may make them difficult to implement
in settings with very limited resources [8]. In rural areas, where specific demographic and
risks groups are often present in low concentrations, health departments and community-
based organizations may lack the resources to offer specialized interventions for every
group. In addition, some specialized interventions require relatively high levels of
monitoring to ensure that the intervention is implemented with the fidelity needed to achieve
optimal efficacy [9, 10]. Smaller organizations may lack the resources that are needed to
deliver and monitor interventions that require high levels of monitoring. Moreover,
interventions that are designed for one demographic or risk group may not be suitable for
others. For example an efficacious intervention for a non-Hispanic white gay-identified man
may not be appropriate for an African-American woman who uses crack cocaine or a
Hispanic heterosexual male who injects heroin. Accordingly, there is a need for an
intervention that can be used with multiple demographic and risk groups and can be
delivered by a single interventionist.
In the past, these challenges have left HIV prevention and STI service providers in many
areas with little choice but to use generic interventions. This is changing now with the
widespread use of computers that allow interventions to be tailored to the characteristics of
each individual [11]. While these interventions hold great promise, they have generally been
designed to be tailored to the characteristics of individuals within certain demographic or
risk groups [11] rather than the broad range of people that HIV prevention and STI service
providers may encounter.
This paper reports intervention effects on condom use in a small randomized field
experiment that tested a brief counselor-delivered cue-card driven, computer-tailored
intervention. The intervention is designed for use with both genders, three major racial/
ethnic groups in the United States and a variety of risk groups including sex workers, MSM,
PWID and stimulants users. It also incorporates counseling and testing for HIV, hepatitis B
virus (HBV), hepatitis C virus (HCV), herpes simplex virus 2 (HSV-2) and syphilis. The
pilot test was conducted in a city. However, we also conducted a feasibility and acceptability
test in which the intervention was delivered by counselors for a community-based
organization to 25 participants in several rural counties in central North Carolina.
Methods
Pilot test
Recruitment—Participants for the pilot test were recruited using a combination of
methods including project flyers that were posted in the community, referrals from current
participants and referrals from the local health department, a women’s center and other
service providers. All participants were recruited in Raleigh, North Carolina between August
2010 and March 2011.
Compensation and Protection of Human Subjects—Participants received $25 as
compensation for the time spent during the baseline interview, $20 for completing Session 1,
$15 for completing Session 2 and $40 for completing the 3-month follow-up interview. All
aspects of the study were approved by the Office of Research Protection at RTI
International.
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Eligibility Requirements—To be eligible for the Computer-assisted Tailored Cue-card
Health (CATCH) study, a participant was required to self-report: being male or female
(people who identified as transgender or transsexual were excluded); a minimum age of 18
years; being African-American, non-Hispanic white, or Hispanic; engaging in male to male
sex, exchanging sex for money or drugs, injecting drug use, or stimulant drug use; speaking
and understanding English well; living in Wake County, North Carolina; and having had
unprotected anal or vaginal sex within the prior 30 days.
Randomization and Sampling—To insure that the intervention and control arms
included equal numbers of men and women in each of the three racial/ethnic groups (i.e.
African-American, non-Hispanic white and Hispanic), we used quota sampling to recruit 20
men and 20 women of each of the three racial/ethnic groups for a total of 120 participants.
We used a block randomization approach in which half of the 20 participants within each of
the six cells (i.e. 2 gender x 3 racial/ethnic categories) were randomized to the delayed-
treatment control arm and half were randomized to the intervention arm. The randomization
resulted in equal numbers of males and females of each racial ethnic group in the two study
arms. For ethical reasons, participants assigned to the delayed treatment control arm were
offered the intervention and biological testing after completion of their 3-month followup
interview.
Theoretical basis of intervention—The CATCH intervention is based on social
cognitive theory. It uses education, which comprises information transmission to increase
knowledge and skill building to influence behavior-specific self-efficacy and outcome
expectations [12]. In addition to providing general information regarding drug use and
diseases, the cue-cards include information that is designed to increase awareness regarding
perceived threats (perceived susceptibility and perceived severity) related to HIV, other STIs
and blood-borne infections, which enhances motivation to reduce risk behaviors. The cue-
cards also include information regarding risk reduction strategies. The provision of
information on risk reduction strategies coupled with skill-building exercises (e.g.,
demonstrations and rehearsals of correct condom application, syringe cleaning, and condom
negotiation) increases perceived self-efficacy to cope with the perceived threats [13, 14].
Intervention format—The CATCH intervention is a 2-session cue-card driven computer-
assisted tailored intervention that is designed to be delivered with fidelity by an
interventionist with minimal training and minimal monitoring. Each session takes between
15 to 45 minutes depending on the number of different risk behaviors a person reports and
the specific tests (e.g. HIV, HBV, HCV, syphilis, HSV-2) that are performed. The
information in Session 1 is tailored to each participant’s gender, race/ethnicity (i.e. African-
American, Hispanic, non-Hispanic white) and risk behaviors and the specific tests (e.g. HIV,
HCV, HBV, syphilis, herpes) that are performed. Session 2 is tailored to a participant’s
specific combination of test results.
Before starting Session 1, basic information—gender (male or female), race/ethnicity,
gender of sex partners, and other behaviors in which they may engage (e.g. injecting drug
use, sex work, or stimulant use)—is gathered from a participant and entered into a startup
form (see Figure 1) that is programmed for use with PowerPoint. The information that is
entered into the startup form determines the specific sequence of slides that the
interventionist reviews with the participant. For example, a Hispanic male who has sex with
both men and women and reports injecting drug use would only see cards for Hispanic
males (i.e., cards with pictures and words relating specifically to Hispanic men). These cue-
cards would include information about risk reduction strategies for people who inject drugs
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and men who have sex with other men as well as with women. Information presented in both
sessions is delivered by an interventionist.
To simplify programming, we developed separate modules for each of the six race/ethnicity
and gender combinations in the study. An example of the tailoring algorithm for Session 1 is
shown in Figure 2 and an example the list of slides and who would see them is shown in
Table I. Examples of actual slides are shown in Figure 3
Within each of the six race/ethnicity gender modules, Session 1 of the intervention was
tailored to the gender of a participant’s sex partners (i.e. male, female or both) and whether
the participant reported exchanging sex for money or drugs, injecting drugs or using
stimulant drugs (e.g. crack cocaine, powder cocaine, methamphetamine). This resulted in 24
possible combinations within each of the six modules for a total of 144 different
combinations. Session 2 was tailored to each participant’s specific combination of test
results. At Session 1, we offered testing to participants assigned to the intervention arm.
Participants assigned to the delayed treatment control arm were offered testing after they
completed their 3-month followup interview. Participants had the option of refusing any or
all tests. For tailoring purposes, the results of each test were classified as positive, negative
or not tested. Additional information regarding the specific tests and results is provided in
the section on testing.
Intervention development—We contacted developers of a number of the evidence-
based interventions that are available through the US Centers for Disease Control and
Prevention (CDC) Diffusion of Effective Behavioral Interventions (DEBI) website
(www.effectiveinterventions.org) to obtain intervention materials and permission to adapt
them for use in this intervention. We were particularly interested in HIV and STI risk
reduction material that was tailored to particular gender and racial/ethnic groups. In the
development stage, we used cultural and educational elements from the following
interventions: STRIVE [15], RESPECT [16], Mujeres Unidas Por La Salud, SAFE [17],
BART [18] and SHIELD [19].
The cue-cards were developed as Microsoft PowerPoint slides (Microsoft Corporation,
Redmond, WA), and the intervention can be delivered on any computer using PowerPoint
viewer (freely available from Microsoft).
The cue-cards were reviewed by 12 expert reviewers. The reviewers included people who
work with each of the demographic and risk groups. Afterwards, we revised the cue-cards to
incorporate comments from the reviewers. The revised cue-cards were then pre-tested with
members (n=19) of the different demographic and risk groups. We made final revisions
based on the results of the pretest.
Intervention content—The introductory section in Session 1 included information on
HIV, hepatitis A, hepatitis B, hepatitis C, syphilis, gonorrhea, chlamydia and genital herpes.
The information was tailored to an individual’s gender and race/ethnicity and included local
HIV prevalence and other statistics based on the individual’s race and gender. After the
introduction, the next section presented sex risk reduction information with particular
partners (either women, men, or both). Each participant saw and discussed risk reduction
information specific to the gender of his or her sex partners. This section included male and
female condom demonstrations as well as role plays and rehearsals of correct condom
application and condom negotiation. The final section presented information and role plays
that centered on the particular behaviors a participant reported (i.e. injecting drug use,
stimulant use, and exchanging sex for money or drugs). Participants only received
information that was relevant to their specific risk activities.
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The information in Session 2 was tailored to the results of the tests that were performed on
the blood sample from Session 1. Session 2 was conducted 5–10 days after Session 1.
Similar to Session 1, the interventionist entered a participant’s test results into the computer
prior to starting the session. The interventionist then provided each participant with
information that was tailored to his or her specific test results. The information covered in
Session 2 described the meaning of each test result (positive or negative). People with a
negative result were given information regarding how to avoid infection. People with a
positive result were given information regarding how to stay healthy and slow disease
progression, how to prevent transmitting the infection and how to disclose their status to
their sex partners. People who tested positive for HCV antibodies were given information as
if they had chronic HCV infection and referred for HCV RNA testing. Participants who
tested positive on one or more tests were offered referrals to appropriate local services for
further evaluation and treatment. The information in Session 2 was not tailored by gender,
race or ethnicity.
HIV, hepatitis and STI tests—Participants in the intervention arm were asked to give
blood samples for HIV antibody, syphilis, HBV surface antigen (HBsAg), HCV antibody
and herpes testing following their first intervention session. The HIV screening test was the
immunochemiluminometric assay (ICMA) Human Immunodeficiency Virus 1/O/2 (HIV-1/
O/2) antibody test; ICMA positive tests were confirmed with a Western Blot. Samples were
tested for hepatitis B and C using enzyme-linked antibody assays (ELISA). Syphilis
screening was performed with a rapid plasma reagin (RPR) test. The confirmatory test was
the treponema pallidum particle agglutination assay (TPPA). Testing for herpes was
performed using the HSV-2 ELISA. All biological samples were processed by Laboratory
Corporation of America (LabCorp, Burlington, NC). Participants assigned to the delayed-
treatment control arm were offered the intervention and testing after they had completed
their followup interview and all activities related to the research.
Data collection—Participants completed an interview at enrollment and a follow-up
interview three months later. Interviews were administered using audio computer-assisted
self-interview (ACASI) technology, which has been shown to reduce social desirability in
responses [20, 21]. The questionnaire covered basic demographic information, drug and
alcohol use, sex risk behaviors, injection risk behaviors, psychological distress, stage of
change regarding sex risk, histories of childhood trauma, health-related quality of live and
HIV and STI testing and status. The sex risk behavior section included detailed questions on
their most recent sexual encounters with up to four different partner types (i.e. a main
partner, a casual partner, someone the participant received money or drugs from in exchange
for sex and someone the participant gave money or drugs in exchange for sex).
Analyses—Because of the small sample and its diversity in terms of demographic
characteristics and risk group composition, primary outcome analyses were limited to
behaviors that were applicable to a wide range of participants. The primary outcomes were
differences at the 3-month followup interview in the occurrence of consistent condom use
during vaginal and anal intercourse during the previous 30 days and condom during vaginal
and or anal intercourse at last sex with a main partner, casual partner, someone to whom the
participant sold sex and someone from whom the participant purchased sex. Encounters that
involved two women were excluded. As secondary outcomes, we assessed condom use
during anal sex in encounters that involved two men and we assessed changes in injecting
drug use. To minimize the effects of recall, only encounters that occurred within the last 30
days were included in the analysis. Since many participants reported on more than one
partner type but few reported on all four partner types, we used a generalized estimating
equations (GEE) approach that allowed us to include everyone in a single model, while
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adjusting for within-subject correlation [22, 23]. We used an unstructured working
correlation structure for the analyses. We also conducted exploratory subgroup analyses
using 2 × 2 contingency tables and odds ratios to examine the impact of the intervention on
each demographic and risk group.
Test of the feasibility and acceptability of the intervention
This intervention was designed to be used in rural areas and non-traditional testing sites such
as mobile units, common space in apartment complexes when testing campaigns are
conducted, homeless shelters or a variety of other settings where HIV testing may be offered
outside of a clinical setting. In a previous study we found that it was more expensive to
recruit high risk samples in rural areas [24], so we conducted the pilot test in a city. To
ensure that the intervention would be appropriate for use in rural areas, we assessed its
acceptability and the feasibility of implementing it in a community-based organization
(CBO) in a rural setting. HIV/STI test counselors for the Chatham Social Health Council
(CSHC), a CBO that provides HIV and STI counseling and testing in several rural counties
in central North Carolina, conducted the feasibility test of the intervention. We trained two
CSHC counselors on the intervention and one of them delivered it to 25 people who were
tested in the CSHC non-traditional testing program, which conducts testing from a mobile
unit (i.e. a van) at sites including apartment complexes and public parks in several rural
counties. Following Session 2 of the intervention participants completed a questionnaire that
included 11 questions, with open-ended responses—which were collapsed into categories
for reporting purposes—pertaining to their experience with the intervention to assess its
acceptability.
Examples of the questions include: (1) Have you been able to use any of the information you
received last week as part of Session 1?; (2) Was there anything you especially liked/
disliked about the sessions? What?; (3) To what extent did the sessions you received tell you
something that you didn’t already know?; (4) Were there any parts of the sessions that were
confusing or hard to understand? Can you give me an example?
Participants in the feasibility and acceptability study were not randomized and did not
complete a followup interview to assess intervention efficacy.
Results
Participants
The block randomization was successful and resulted in equal numbers of males and females
of each racial/ethnic group assigned to each study arm. There were no significant differences
in other socio-demographic characteristics or sex risk behaviors between arms. However,
crack cocaine use, heroin use and injecting drug use were significantly higher in the control
arm than in the intervention arm. Fifty-eight participants (97%) assigned to the intervention
arm agreed to be tested for HIV, HBV, HCV, syphilis and HSV-2 at baseline. Biological
testing and participation in the intervention among people who were assigned to the control
arm were not part of the research. The intervention and testing were offered as a service to
participants in the delayed-treatment control arm after they completed their followup
interview. Thirty participants (61% of those completing a followup interview) in the
delayed-treatment control arm participated in the intervention and testing. Overall
prevalence was 7% for HIV, 3% for HBV surface antigen, 19% for HCV antibodies, 7% for
syphilis and 57% for HSV-2. Characteristics of the sample are shown by study arm in Table
II.
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The overall follow-up rate was 88% (105/120). Only 82% (49/60) of participants assigned to
the control arm completed a followup interview compared with 93% (56/60) of participants
assigned to the intervention arm. These differences were marginally significant (p = 0.053).
Follow-up rates differed significantly (p = 0.012) by race with 95% (38/40) of African-
Americans, 95% (38/40) of non-Hispanic whites and 75% (30/40) of Hispanics completing a
3-month follow-up interview. Of the 15 people who did not complete a followup interview,
there were five in the control arm and one in the intervention arm who we were unable to
locate. A CONSORT diagram for participation in each activity of the study is shown in
Figure 4.
Intervention outcomes: sex risk
In logistic regression analyses that adjusted for consistent condom use at baseline,
participants in the intervention arm were somewhat more likely than participants in the
control arm to report consistent use at followup (Odds ratio [OR] = 3.06; 95% Confidence
Interval [C.I.] 0.86, 10.92; p = 0.084). In GEE logistic regression analyses that adjusted for
partner type, at followup, participants in the intervention arm were over four times more
likely than participants in the control arm to report condom use at their last sexual encounter
involving vaginal and or anal intercourse (OR = 4.75; 95% C.I. = 1.70, 13.26; p = 0.003). In
GEE analyses of encounters that involved a man and a woman and adjusted for partner type,
compared with participants in the control arm, participants assigned to the intervention arm
were more likely to report using condoms (OR = 4.15; 95% C.I. 1.46, 11.78; p = 0.008). The
unadjusted and adjusted results for each outcome are shown in Table III.
We also conducted exploratory analyses that used simple contingency tables, which did not
adjust for within subject correlation, to assess intervention effects separately for each partner
type, racial/ethnic group, gender and risk group. In all 10 subgroup analyses, the percentage
of participants in the intervention arm reporting condom use was higher than the percentage
in the control arm (Table IV). The odds ratios were lowest in subgroup analyses for condom
use with a main partner (OR = 1.96; 95% C.I. = 0.61, 6.30), for African-Americans (OR =
2.87; 95% C.I. = 0.87, 9.45) and for men (OR = 2.92; 95% C.I. = 0.96, 8.84). In the 12
MSM encounters (6 per study arm), 0% in the control and 67% in the intervention arm
reported using condoms. These subgroup analyses are presented to give the reader a sense of
the response to the intervention within each group. Due to the small numbers in many of the
cells, the p-values and odds ratios should be interpreted cautiously.
Intervention outcomes: injection risk
At baseline, 21 people in the control arm and 11 people in the intervention arm reported
injecting in the previous 30 days. Among those who were injecting, the frequency was
somewhat lower in the control arm than in the intervention arm with a mean of 4.9 (standard
deviation [S.D.] = 5.5) injections in the control arm and a mean of 10.8 (S.D. = 8.1) in the
intervention arm t= −2.35, df=29, p = 0.026). Five of the injectors in the control arm and one
of the injectors in the intervention arm did not complete a followup interview. Of those who
were not injecting at baseline and completed a followup interview, 12% (4/33) in the control
arm and 0% (0/46) in the intervention arm were injecting at followup. Of those who were
injecting at baseline, 25% (4/16) in the control arm and 11% (1/9) were injecting at
followup. With only five people who reported injecting at followup, statistical analyses of
injection risk are not appropriate.
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Propensity score adjustment to assess potential impact of imbalance of confounders
across study conditions on condom use at followup
The slightly higher percentages of participants in the control arm that reported use of crack
cocaine, heroin and injecting drug in the previous 30 days suggest that the randomization did
not achieve balance between study arms on some important potential confounders. This is
not surprising given the small sample. Nonetheless it raises the possibility that these
differences could have influenced the intervention effects on condom use. Accordingly, we
conducted additional analyses using propensity score weighting to adjust for these
differences. This approach is widely used in observational studies to adjust for differences
between who are exposed to a treatment or risk and those who are not [25–28]. The
differences between the unweighted and weighted analyses were relatively small. For
example, the results for the unweighted analyses of consistent condom use during the last 30
days were: OR = 3.25 (95% C.I. = 0.94, 11.24; p = 0.063 while results for the weighted
analyses were OR = 4.42 (95% C.I. = 1.06, 18.35; p = 0.041). Similarly, the results for the
unweighted analysis of condom use at last sex were: OR = 6.30 (95% C.I. = 2.14, 18.55; p =
0.001) while results for the weighted analysis were OR = 4.42 (95% C.I. = 1.75, 11.17; p =
0.002).
Feasibility and acceptability
The CSHC counselor was able to deliver the intervention as part of the mobile testing
program without any problems. The intervention was delivered both from a van and in
common space at apartment complexes in several rural counties. This suggests that the
intervention may be feasible for use in field settings as well as in an office setting like the
one used for the pilot test. One participant in the acceptability study refused to answer
questions regarding the intervention that were asked at the end of the second session. Of the
24 that responded, 23 reported that they had already been able to apply information they had
learned at Session 1. Nineteen participants reported that they learned something new during
the intervention and 19 reported being either satisfied or very satisfied with it. Fifteen
participants were satisfied with the length of the sessions, but nine thought the sessions
should be shorter. Of 17 who had been tested for at least two of the five infections
previously, 14 preferred this counseling over their previous experience. Twenty participants
reported that they would be willing to take part in the intervention again, even without any
incentive.
Discussion
Compared with participants assigned to the control arm, participants assigned to the
intervention arm were more likely to report condom use and less likely to report unprotected
intercourse during recent sexual encounters at followup interviews completed 3 months after
taking part in the intervention. These findings are consistent with other studies, which have
shown that brief interventions using a client-centered or tailored approach may be
efficacious [16, 29]. Although the numbers were too small to draw firm conclusions,
compared with participants in the control arm, participants in the intervention arm who
reported MSM encounters were more likely to use condoms during anal intercourse. The
number of people who reported injecting at followup was too small draw any meaningful
conclusions regarding the effect of the intervention on injection risk.
Limitations
The slightly lower followup rates 82% (49/60) in the control arm than in the intervention
arm 93% (56/60) raise the possibility of differential attrition. In general this is more of a
concern when followup rates are lower in the intervention arm. We are not aware of any
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studies that suggest that people in a control group who are doing better are more likely to
drop out.
While the intervention shows promise, future studies will require longer followup periods in
order to determine if the effects are sustained [30]. The intervention will also need to be
compared with standard practice. Meaningful subgroup analyses of the intervention’s impact
on specific demographic and risk groups will require much larger samples.
As with most studies of interventions to reduce HIV risk among people who use drugs,
people who engage in transactional sex and MSM, this study relies on self-reports of
behavior change. Several studies that compared self-reports of unprotected sex with
biomarkers found evidence of underreporting of unprotected sex [31–33]. Data in this study
were collected using ACASI technology, which has been shown to minimize socially
desirable responses and increase reporting of potentially embarrassing and stigmatizing
behaviors [20, 31, 34], nonetheless it is likely that risk behaviors may be underreported. One
possible solution to problems associated with underreporting would be to use incident STIs
as a biological outcome. However, such a study would probably require a very large sample,
which would make it very expensive. Another limitation arises from the fact that the sample
was not recruited using probability sampling techniques. So the extent to which the findings
may be generalized to other groups is unknown.
The intervention was designed to address both sex and injection risk behaviors, however, too
few people in the sample reported injecting at follow-up to assess, with any confidence,
changes in sharing of syringes or other injection equipment. Similarly, due to the small
sample, analyses by risk group, gender and racial/ethnic group are only exploratory and the
results should be interpreted cautiously.
Participants were randomized to receive the intervention or to a delayed-treatment control
condition. By design, participants assigned to the delayed treatment control condition did
not receive any intervention until after they had completed their 3-month followup
interview. Therefore, although it appears that the intervention works better than no
intervention, we do not know if it would work better than standard care. In addition, most
participants (97%) who were assigned to the intervention arm were tested for HIV, HBV,
HCV, syphilis and HSV-2 as part of the intervention; whereas participants in the delayed
treatment control condition were not offered testing at baseline. However, we conducted
subgroup analyses (not shown) of participants in the intervention condition to assess the
impact of HSV-2 (the most common STI in the sample) test results on risk behaviors, and
there was no association.
Conclusions
It is important to note that because the intervention is very brief and it is designed to be used
with most demographic and risk groups, it is unlikely to be as powerful as more intensive or
specialized interventions.
Given those caveats, the results of this pilot study suggest that the intervention may be
efficacious in reducing risk behaviors. If the intervention proves efficacious and cost
effective in a larger randomized field experiment, it could provide a useful tool for HIV
prevention in rural areas and other areas where risk groups are present in relatively low
numbers as well as other settings where it is impractical to offer a range of more specialized
or intensive interventions.
Zule et al. Page 9














We are grateful for the assistance of Steffanie Strathdee, Sebastian Bonner, Anita Raj, Rochelle Shain, Janet St.
Lawrence, and Melissa Davey-Rothwell who shared their evidence-based interventions with us and granted us
permission to incorporate elements of them into this intervention. This project was funded by NIH Grant number
R21DA026771 from the National Institute on Drug Abuse.
References
1. CDC. Compendium of Evidence-Based HIV Behavioral Interventions: Risk Reduction Chapter.
2012.
2. Coury-Doniger P, et al. HIV prevention interventions for black MSM. American Journal of Public
Health. 2010; 100(2):198. [PubMed: 20019294]
3. Crepaz N, et al. The efficacy of HIV/STI behavioral interventions for African American females in
the United States: A meta-analysis. American Journal of Public Health. 2009; 99(11):2069–2078.
[PubMed: 19762676]
4. Darbes L, et al. The efficacy of behavioral interventions in reducing HIV risk behaviors and incident
sexually transmitted diseases in heterosexual African Americans. AIDS. 2008; 22(10):1177–1194.
[PubMed: 18525264]
5. Herbst JH, et al. A systematic review and meta-analysis of behavioral interventions to reduce HIV
risk behaviors of Hispanics in the United States and Puerto Rico. AIDS Behav. 2007; 11(1):25–47.
[PubMed: 16917668]
6. Lyles CM, et al. Best-evidence interventions: Findings from a systematic review of HIV behavioral
interventions for US populations at high risk, 2000–2004. American Journal of Public Health. 2007;
97(1):133–143. [PubMed: 17138920]
7. Owczarzak J, Dickson-Gomez J. Provider perspectives on evidence-based HIV prevention
interventions: barriers and facilitators to implementation. AIDS Patient Care STDS. 2011; 25(3):
171–9. [PubMed: 21323564]
8. Rietmeijer CA. The max for the minimum: brief behavioral interventions can have important HIV
prevention benefits. Aids. 2003; 17(10):1561–2. [PubMed: 12824795]
9. Kelly JA, Spielberg F, McAuliffe TL. Defining, designing, implementing, and evaluating phase 4
HIV prevention effectiveness trials for vulnerable populations. J Acquir Immune Defic Syndr. 2008;
47(Suppl 1):S28–33. [PubMed: 18301131]
10. Veniegas RC, et al. HIV prevention technology transfer: challenges and strategies in the real
world. Am J Public Health. 2009; 99(Suppl 1):S124–30. [PubMed: 19218184]
11. Noar SM, et al. Using computer technology for HIV prevention among African-Americans:
Development of a tailored information program for safer sex (TIPSS). Health Education Research.
2011; 26(3):393–406. [PubMed: 21257676]
12. Bandura A. Health promotion by social cognitive means. Health Educ Behav. 2004; 31(2):143–64.
[PubMed: 15090118]
13. Bandura A. Perceived self-efficacy in the exercise of control over AIDS infection. Evaluation and
Program Planning. 1990; 13(1):9–17.
14. Bandura, A. Self-efficacy: The exercise of control. New York: W.H. Freeman and Company; 1997.
15. Latka MH, et al. A randomized intervention trial to reduce the lending of used injection equipment
among injection drug users infected with hepatitis C. Am J Public Health. 2008; 98(5):853–61.
[PubMed: 18382005]
16. Kamb ML, et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus
and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group.
JAMA. 1998; 280(13):1161–7. [PubMed: 9777816]
17. Shain RN, et al. A randomized, controlled trial of a behavioral intervention to prevent sexually
transmitted disease among minority women. N Engl J Med. 1999; 340(2):93–100. [PubMed:
9887160]
18. St Lawrence JS, et al. Cognitive-behavioral intervention to reduce African American adolescents’
risk for HIV infection. J Consult Clin Psychol. 1995; 63(2):221–37. [PubMed: 7751483]
Zule et al. Page 10













19. Latkin CA, Sherman S, Knowlton A. HIV prevention among drug users: outcome of a network-
oriented peer outreach intervention. Health Psychol. 2003; 22(4):332–9. [PubMed: 12940388]
20. Metzger DS, et al. Randomized controlled trial of audio computer-assisted self-interviewing: utility
and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team.
Am J Epidemiol. 2000; 152(2):99–106. [PubMed: 10909945]
21. Rogers SM, et al. Audio computer assisted interviewing to measure HIV risk behaviours in a clinic
population. Sex Transm Infect. 2005; 81(6):501–7. [PubMed: 16326855]
22. Diggle, P., et al. Oxford statistical science series. 2. Oxford; New York: Oxford University Press;
2002. Analysis of longitudinal data; p. xvp. 379
23. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics.
1986; 42(1):121–30. [PubMed: 3719049]
24. Bobashev GV, et al. Transactional sex among men and women in the south at high risk for HIV
and other STIs. J Urban Health. 2009; 86(Suppl 1):32–47. [PubMed: 19513853]
25. Austin PC. An Introduction to Propensity Score Methods for Reducing the Effects of Confounding
in Observational Studies. Multivariate Behavioral Research. 2011; 46(3):399–424. [PubMed:
21818162]
26. D’Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to
a non-randomized control group. Stat Med. 1998; 17(19):2265–81. [PubMed: 9802183]
27. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for
causal effects. Biometrika. 1983; 70(1):41–55.
28. Rubin DB. Propensity score methods. Am J Ophthalmol. 2010; 149(1):7–9. [PubMed: 20103037]
29. Scholes D, et al. A tailored minimal self-help intervention to promote condom use in young
women: Results from a randomized trial. AIDS. 2003; 17(10):1547–1556. [PubMed: 12824793]
30. Gagnon H, et al. A randomized trial to evaluate the efficacy of a computer-tailored intervention to
promote safer injection practices among drug users. AIDS Behav. 2010; 14(3):538–48. [PubMed:
20033276]
31. Langhaug LF, Sherr L, Cowan FM. How to improve the validity of sexual behaviour reporting:
systematic review of questionnaire delivery modes in developing countries. Trop Med Int Health.
2010; 15(3):362–81. [PubMed: 20409291]
32. Gallo MF, et al. Predictors of unprotected sex among female sex workers in Madagascar:
comparing semen biomarkers and self-reported data. AIDS Behav. 2010; 14(6):1279–86.
[PubMed: 20625928]
33. Gallo MF, et al. Prostate-specific antigen to ascertain reliability of self-reported coital exposure to
semen. Sex Transm Dis. 2006; 33(8):476–9. [PubMed: 16865047]
34. Simoes AA, et al. A randomized trial of audio computer and in-person interview to assess HIV risk
among drug and alcohol users in Rio De Janeiro, Brazil. J Subst Abuse Treat. 2006; 30(3):237–43.
[PubMed: 16616168]
Zule et al. Page 11













Figure 1. Pre-intervention startup screen to select demographic and risk behaviors of a
participant
Note: The information selected here automatically determines the information that will be
presented and the order in which it is presented.
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Figure 2. Algorithm for intervention Session 1*
*The intervention is divided into six modules—one module for males and one for females
within each of the three racial/ethnic groups. The diagram above illustrates the decision tree
an African-American male. Each of the decisions are based on the characteristics selected
the startup screen before the intervention actually starts. The information that is entered in
the startup form automatically determines the specific slides that are displayed, which are
automatically tailored to the characteristics of the participant. The interventionist and the
participant review the material on the slides together
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Example of slides from the tailored intervention of the Computer-assisted Tailored Cue-card
Health Study
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CONSORT diagram of participation by study arm in the Computer-assisted Tailored Cue-
card Health Study
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Table I
List of slides for Session I with specific examples of slides that would be seen by an African-American male
MSM who does not inject or use stimulants and an African-American MSMW who injects drugs and smokes
crack. (from the Computer-assisted Tailored Cue-card Health Study)
African-American male examples
Slide# Content Topic
MSM no drug use or sex
trading
MSMW, PWID, smokes crack
cocaine
1 Introduction Slide X X
2 Preview to Session I X X
3 HIV/AIDS Information Disease Info X X
4 Hepatitis Overview Disease Info X X
5 Hepatitis A Disease Info X X
6 Hepatitis B Disease Info X X
7 Hepatitis C Disease Info X X
8 HIV/Hepatitis Transmission 1 Disease Info X X
9 HIV/Hepatitis Transmission 2 Disease Info X X
10 Syphilis Disease Info X X
11 Herpes Disease Info X X
12 Tailored Risk Slide 1 Tailored X
13 Tailored Risk Slide 2 Tailored X
14 Tailored Risk Slide 1 Tailored X
15 Tailored Risk Slide 2 Tailored X
16 Tailored Risk Slide 1 Tailored
17 Tailored Risk Slide 2 Tailored
18 Sexual Activity Risk Sex Risk X X
19 Sex with Women MSMW Risk X
20 Sex with Men MSM/MSMW Risk X
21 Condom Use Exercise Sex Risk X X
22 Condom negotiation Slide 1 Sex Risk X X
23 Condom negotiation Slide 2 Sex Risk X X
24 Trading Sex CSW Risk
25 Trading Sex CSW Risk
26 Injection Drug Use Risk IDU Risk X
27 Injection Drug Use Risk Reduction IDU Risk X
28 Syringe Cleaning Exercise IDU Risk X
29 IDU Treatment and Support IDU Risk X
30 Stimulant Drug Use Risk Stimulant Risk X
31 Stimulant Drug Use Risk Reduction Stimulant Risk X
32 Review and Session II Preview X X
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Table II
Comparison of the participants in the delayed treatment control and computer tailored intervention arms of the






Computer-tailored intervention (n=60) Pearson Chi-square/t-value p-value
 % female 50 50 --
 % African-American 33 33 --
 % Hispanic 33 33 --
 % non-Hispanic white 33 33 --
 Mean age (S.D.) in years 38.8 (12.6) 38.2 (11.0) 0.788
 % High school graduate 38.3 41.7 0.139 0.709
 % unemployed 68.3 73.3 0.363 0.547
 % married or living as married 15.0 11.7 0.288 0.591
HIV, HBV, HCV, syphilis and
HSV-2 test resultsa
 % HIV positive 6.9 6.9 0.000 1.000
 % HBV surface antigen positive 3.4 3.4 0.000 1.000
 % HCV antibody positive 17.2 19.0 0.038 1.000
 % syphilis positive 3.4 8.6 0.806 0.369
 % HSV-2 positive 58.6 56.9 0.024 0.878
History of substance abuse
treatment and incarceration
 % ever in substance abuse treatment 55.0 65.0 0.264
 % ever in jail or prison 78.3 70.0 1.087 0.297
Alcohol and drug use past 30 days
 Mean # days drank 5 or more drinks
(S.D.)
8.6 (10.2) 7.7 (9.1) 0.486 0.628
 % used crack cocaine 81.7 65.0 4.261 0.039
 % used powder cocaine 55.0 43.3 1.634 0.201
 % used heroin 21.7 8.3 4.183 0.041
 % used amphetamine or
methamphetamine
15.0 8.3 1.294 0.255
 % injected 35.0 18.3 4.261 0.039
Sexual behavior past 30 days
 Mean # sex partners (S.D.) 6.4 (15.2) 5.0 (8.2) 0.636 0.526
 Mean # partners unprotected sex
(S.D.)
3.5 (5.0) 3.3 (7.5) −0.014 0.989
 % any unprotected vaginal or anal
intercourse
91.7 93.3 0.729
 % male to male sex (% based on 30
males per study arm)
40.0 50.0 0.606 0.436
 % traded sex for money or drugs 68.3 58.3 1.292 0.256



















Computer-tailored intervention (n=60) Pearson Chi-square/t-value p-value
 % traded drugs or money for sex 43.3 50.0 0.536 0.464
*
Participants were enrolled in Raleigh, North Carolina in 2010 and 2011
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